STEMI VE NSTEMI OLGULARINDA COVID-19 KORKUSU VE TEDAVİNİN ERTELENMESİ ARASINDAKİ İLİŞKİNİN İNCELENMESİ

Bu çalışma içinde bulunduğumuz COVID-19 pandemisinde Miyokard Enfarktüsü (STEMI-NSTEMI) geçiren bireylerin ilk semptomların başlaması ile hastaneye başvurusu arasında geçen süre ile COVID-19 korkusu arasındaki ilişkiyi değerlendirmek amacıyla gerçekleştirilmiştir. Tanımlayıcı türdeki bu çalışma 10 Aralık 2020 ile ülkemizde ilk vakanın saptanmasının yıldönümü olan 10 Mart 2021 tarihi arasında, bir eğitim ve araştırma hastanesine başvuran, STEMI ve NSTEMI tanı kriterlerine uyan ve primer perkütan koroner girişim (PPKG) yapılan 31 hasta ile yapıldı. Bir yıl önce aynı zaman aralığında PPKG yapılan, aynı tanıya sahip 31 hasta kontrol grubu olarak çalışmaya dahil edildi. COVID-19 pandemisi öncesinde hastaların ilk semptom ile hastaneye başvuru arasında geçen süre 33.95±61.64 (median 2 saat) saat iken, pandemi döneminde bu sürenin 264±586.064 (median 12 saat) saat olduğu ve aralarındaki farkın anlamlı olduğu belirlendi. Yapılan çoklu regresyon analizine göre COVID-19 döneminde ertelenen tedavi ile hastaların COVID-19 korkusu arasında bir ilişki olmadığı saptandı. Hastaların COVID-19 korkusuna karşı farkındalık geliştirebilecekleri varsayılsa da yüksek kardiyovasküler hastalık riskine sahip hastalara yardımcı olmak için önlemler alınmalı ve akut olaylar durumunda hastaneye zamanında erişim sağlamaları için rehberlik edilmelidir.

Anahtar Kelimeler:

Covid-19, Korku, Miyokard infarktüsü.

Investigation of the Relationship Between Fear of COVID-19 and Delay of Treatment in Patients with STEMI and NSTEMI

This study has been conducted to evaluate the relationship between the time between the onset of the first symptoms and the admission to the hospital, and the fear of COVID-19 in individuals who had Myocardial Infarction (STEMI-NSTEMI) in the current COVID-19 pandemic. This descriptive study was conducted with 31 patients who applied to a training and research hospital, met the diagnostic criteria for STEMI and NSTEMI and underwent primary percutaneous coronary intervention (PPKG), between 10 December 2020 and 10 March 2021, the anniversary of the first case detection in our country. Thirty-one patients with the same diagnosis, who had PPCG at the same time one year ago, were included in the study as the control group. While the time between the first symptom and admission to the hospital was 33.95±61.64 (median 2 hours) hours during the non-COVID -19 pandemic period, it was determined to be 264±586.064 (median 12 hours) hours during the pandemic period, and the difference between them was found to be significant. According to the multiple regression analysis, it was determined that there was no relationship between the treatment delayment during the COVID-19 period and the patients' fear of COVID-19. Although it is assumed that patients can develop awareness of the fear of COVID-19, measures should be taken to assist patients at high risk of cardiovascular disease and should be guided to ensure timely access to the hospital in the acute events.

Keywords:

Covid-19, Fear, Myocardial infarction.,

PDF

___

Ahorsu, D. K., Lin, C.-Y., Imani, V., Saffari, M., Griffiths, M. D. ve Pakpour, A. H. (2020). The fear of COVID-19 scale: development and initial validation. International Journal of Mental Health and Addiction., 27, 1-9.
Aktaş, H., Yıldırım, O., Gül, M. ve İnci, S. (2021). COVID-19 Pandemi sürecinde koroner anjiyografi yapılan akut miyokard enfarktüslü hastaların pandemi öncesi dönemle karşılaştırılması. MN Kardiyoloji, 28(4), 199-205.
Alahmadi, A. F., ALSaedi, M. F., Alahmadi, A. E., Alharbi, M. G., Alharbi, I. H. ve Al-Dubai, S. A. R. (2020). Pre-hospital delay among patients with acute myocardial infarction in Saudi Arabia: A cross-sectional study. Saudi Medical Journal, 41(8), 819-827.
Albarqouni, L., Smenes, K., Meinertz, T., Schunkert, H., Fang, X., Ronel, J. ve Ladwig, K.-H. (2016). Patients’ knowledge about symptoms and adequate behaviour during acute myocardial infarction and its impact on delay time: Findings from the multicentre MEDEA Study. Patient education and counseling, 99(11), 1845-1851.
Anderson, J. L. ve Morrow, D. A. (2017). Acute myocardial infarction. New England Journal of Medicine, 376(21), 2053-2064. Bakioğlu, F., Korkmaz, O. ve Ercan, H. (2020). Fear of COVID-19 and Positivity: Mediating role of intolerance of uncertainty, depression, anxiety, and stress. International Journal of Mental Health and Addiction, 28,1-14.
Çinier, G., Hayıroğlu, M., Pay, L., Yumurtaş, A., Tezen, O., Parsova, K. E. ve Tekkesin, I. (2020). Effect of the COVID-19 pandemic on access to primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Turk Kardiyoloji Derneği Arşivi, 48(7), 640-645.
De Luca, G., Suryapranata, H., Ottervanger, J. P. ve Antman, E. M. (2004). Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts. Circulation, 109(10), 1223-1225.
Garcia, S., Albaghdadi, M. S., Meraj, P. M., Schmidt, C., Garberich, R., Jaffer, F. A., ...Chambers, J. (2020). Reduction in ST-segment elevation cardiac catheterization laboratory activations in the United States during COVID-19 pandemic. Journal of the American College of Cardiology, 75(22), 2871-2872.
Garrido, D., Petrova, D., Catena, A., Ramírez-Hernández, J. A. ve Garcia-Retamero, R. (2020). Recognizing a Heart attack: patients’ knowledge of cardiovascular risk factors and its relation to prehospital decision delay in acute coronary syndrome. Frontiers in Psychology, 11, 2056.
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., ...Cao, B. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 395(10223), 497-506.
Kristensen, S. D. ve Aboyans, V. (2018). 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. European Heart Journal, 39, 119-177.
Kusumoto, F. M., Schoenfeld, M. H., Barrett, C., Edgerton, J. R., Ellenbogen, K. A., Gold, M. R., …Kim, R. J. (2019). 2018 ACC/AHA/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay: executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society. Journal of the American College of Cardiology, 74(7), 932-987.
Lantelme, P., Targe, S. C., Metral, P., Bochaton, T., Ranc, S., Zaimi, M. L. B., …Harbaoui, B. (2020). Worrying decrease in hospital admissions for myocardial infarction during the COVID-19 pandemic. Archives of Cardiovascular Diseases, 113(6-7), 443-447.
Mahase, E. (2020). China coronavirus: WHO declares international emergency as death toll exceeds 200. BMJ, 368, m408. doi:10.1136/bmj.m408
Marotta, M., Gorini, F., Parlanti, A., Chatzianagnostou, K., Mazzone, A., Berti, S. ve Vassalle, C. (2021). Fear of COVID-19 in Patients with Acute Myocardial Infarction. International Journal of Environmental Research and Public Health, 18(18), 9847.
Mesnier, J., Cottin, Y., Coste, P., Ferrari, E., Schiele, F., Lemesle, G., …Bouleti, C. (2020). Hospital admissions for acute myocardial infarction before and after lockdown according to regional prevalence of COVID-19 and patient profile in France: a registry study. The Lancet Public Health, 5(10), e536-e542.
Moser, D. K., Kimble, L. P., Alberts, M. J., Alonzo, A., Croft, J. B., Dracup, K., …Kothari, R. U. (2007). Reducing delay in seeking treatment by patients with acute coronary syndrome and stroke: a scientific statement from the American Heart Association Council on Cardiovascular Nursing and Stroke Council. Journal of Cardiovascular Nursing, 22(4), 326-343.
Primessnig, U., Pieske, B. M. ve Sherif, M. (2021). Increased mortality and worse cardiac outcome of acute myocardial infarction during the early COVID‐19 pandemic. ESC Heart Failure, 8(1), 333-343.
Rangé, G., Hakim, R. ve Motreff, P. (2020). Where have the ST-segment elevation myocardial infarctions gone during COVID-19 lockdown? EHJ-QCCO, 6(3), 223-224
Reinstadler, S. J., Reindl, M., Lechner, I., Holzknecht, M., Tiller, C., Roithinger, F. X., …Berger, R. (2020). Effect of the COVID-19 pandemic on treatment delays in patients with ST-segment elevation myocardial infarction. Journal of Clinical Medicine, 9(7), 2183.
Riegel, B., McKinley, S., Moser, D. K., Meischke, H., Doering, L. ve Dracup, K. (2007). Psychometric evaluation of the acute coronary syndrome (ACS) response index. Research in Nursing & Health, 30(6), 584-594.
Solomon, M. D., McNulty, E. J., Rana, J. S., Leong, T. K., Lee, C., Sung, S.-H., …Go, A. S. (2020). The Covid-19 pandemic and the incidence of acute myocardial infarction. New England Journal of Medicine. 383(7), 691-693.
Wang, C., Horby, P. W., Hayden, F. G. ve Gao, G. F. (2020). A novel coronavirus outbreak of global health concern. Lancet, 395(10223), 470-473. doi:10.1016/s0140-6736(20)30185-9
Yıldız, M. ve Enç, N. (2016) Akut koroner sendrom yanıt indeksi geçerlik ve güvenirlik çalışması (Yüksek lisans tezi). İstanbul: İstanbul Üniversitesi.